Annual Current Assets
$9.91 M
+$751.00 K+8.20%
December 31, 2023
Summary
- As of February 7, 2025, CANF annual total current assets is $9.91 million, with the most recent change of +$751.00 thousand (+8.20%) on December 31, 2023.
- During the last 3 years, CANF annual current assets has risen by +$508.00 thousand (+5.40%).
- CANF annual current assets is now -50.63% below its all-time high of $20.07 million, reached on December 31, 2021.
Performance
CANF Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$5.83 M
-$4.08 M-41.18%
June 30, 2024
Summary
- As of February 7, 2025, CANF quarterly total current assets is $5.83 million, with the most recent change of -$4.08 million (-41.18%) on June 30, 2024.
- Over the past year, CANF quarterly current assets has dropped by -$5.08 million (-46.58%).
- CANF quarterly current assets is now -70.96% below its all-time high of $20.07 million, reached on December 31, 2021.
Performance
CANF Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
CANF Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.2% | -46.6% |
| 3 y3 years | +5.4% | -39.0% |
| 5 y5 years | +25.4% | -57.2% |
CANF Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.6% | +8.2% | -71.0% | at low |
| 5 y | 5-year | -50.6% | +38.7% | -71.0% | at low |
| alltime | all time | -50.6% | +525.5% | -71.0% | +356.5% |
Can-Fite BioPharma Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $5.83 M(-41.2%) |
| Dec 2023 | $81.00 K(-35.7%) | $9.91 M(+9.3%) |
| Sep 2023 | - | $9.06 M(-16.9%) |
| Jun 2023 | - | $10.91 M(-18.5%) |
| Mar 2023 | - | $13.38 M(+46.1%) |
| Dec 2022 | $126.00 K(-31.9%) | $9.16 M(-27.1%) |
| Sep 2022 | - | $12.56 M(-13.9%) |
| Jun 2022 | - | $14.59 M(-17.5%) |
| Mar 2022 | - | $17.67 M(-11.9%) |
| Dec 2021 | $185.00 K(+50.4%) | $20.07 M(+38.6%) |
| Sep 2021 | - | $14.47 M(+51.5%) |
| Jun 2021 | - | $9.55 M(-24.3%) |
| Mar 2021 | - | $12.63 M(+34.3%) |
| Dec 2020 | $123.00 K(-88.1%) | $9.40 M(-29.0%) |
| Sep 2020 | - | $13.24 M(+4.2%) |
| Jun 2020 | - | $12.70 M(+77.8%) |
| Dec 2019 | $1.03 M(+2002.0%) | - |
| Dec 2019 | - | $7.14 M(-28.2%) |
| Sep 2019 | - | $9.95 M(-26.9%) |
| Jun 2019 | - | $13.62 M(+83.1%) |
| Mar 2019 | - | $7.44 M(-5.9%) |
| Dec 2018 | $49.00 K(-94.8%) | - |
| Dec 2018 | - | $7.90 M(-18.6%) |
| Sep 2018 | - | $9.71 M(+6.3%) |
| Jun 2018 | - | $9.13 M(-20.8%) |
| Mar 2018 | - | $11.52 M(+72.9%) |
| Dec 2017 | $950.00 K | - |
| Dec 2017 | - | $6.66 M(-23.5%) |
| Sep 2017 | - | $8.71 M(-14.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $10.23 M(-16.1%) |
| Mar 2017 | - | $12.20 M(+20.7%) |
| Dec 2016 | $62.90 K(-6.7%) | - |
| Dec 2016 | - | $10.10 M(-14.0%) |
| Sep 2016 | - | $11.75 M(-14.5%) |
| Jun 2016 | - | $13.75 M(-15.9%) |
| Mar 2016 | - | $16.35 M(-6.7%) |
| Dec 2015 | $67.40 K(+65.2%) | - |
| Dec 2015 | - | $17.53 M(+15.8%) |
| Sep 2015 | - | $15.14 M(+78.6%) |
| Jun 2015 | - | $8.48 M(-14.5%) |
| Mar 2015 | - | $9.92 M(-2.2%) |
| Dec 2014 | $40.80 K(-19.7%) | - |
| Dec 2014 | - | $10.15 M(+110.6%) |
| Sep 2014 | - | $4.82 M(-24.5%) |
| Jun 2014 | - | $6.38 M(-26.4%) |
| Mar 2014 | - | $8.67 M(+31.7%) |
| Dec 2013 | $50.80 K(-0.6%) | $6.58 M(+108.1%) |
| Sep 2013 | - | $3.16 M(-30.5%) |
| Jun 2013 | - | $4.55 M(-22.6%) |
| Mar 2013 | - | $5.88 M(+271.0%) |
| Dec 2012 | $51.10 K(-30.0%) | - |
| Dec 2012 | - | $1.58 M(-36.6%) |
| Sep 2012 | - | $2.50 M(-27.4%) |
| Jun 2012 | - | $3.44 M(-5.9%) |
| Mar 2012 | - | $3.66 M(-24.3%) |
| Dec 2011 | $73.00 K | - |
| Dec 2011 | - | $4.83 M(+278.3%) |
| Sep 2011 | - | $1.28 M |
FAQ
- What is Can-Fite BioPharma annual total current assets?
- What is the all time high annual current assets for Can-Fite BioPharma?
- What is Can-Fite BioPharma annual current assets year-on-year change?
- What is Can-Fite BioPharma quarterly total current assets?
- What is the all time high quarterly current assets for Can-Fite BioPharma?
- What is Can-Fite BioPharma quarterly current assets year-on-year change?
What is Can-Fite BioPharma annual total current assets?
The current annual current assets of CANF is $9.91 M
What is the all time high annual current assets for Can-Fite BioPharma?
Can-Fite BioPharma all-time high annual total current assets is $20.07 M
What is Can-Fite BioPharma annual current assets year-on-year change?
Over the past year, CANF annual total current assets has changed by +$751.00 K (+8.20%)
What is Can-Fite BioPharma quarterly total current assets?
The current quarterly current assets of CANF is $5.83 M
What is the all time high quarterly current assets for Can-Fite BioPharma?
Can-Fite BioPharma all-time high quarterly total current assets is $20.07 M
What is Can-Fite BioPharma quarterly current assets year-on-year change?
Over the past year, CANF quarterly total current assets has changed by -$5.08 M (-46.58%)